References

1. National Osteoporosis Foundation.

2. Rubenstein LZ, Josephson KR, Robbins AS. Falls in the nursing home. Ann Intern Med. 1994 Sep 15;121(6):442-51.

3. Tinetti ME, Speechley M. Prevention of falls among the elderly. N Engl J Med. 1989 Apr 20;320(16):1055-9.

4. Ross PD. Osteoporosis. Frequency, consequences, and risk factors. Arch Intern Med. 1996 Jul 8;156(13):1399-411.

5. Riggs BL, Melton LJ 3^rd. Involutional osteoporosis. N Engl J Med. 1986 Jun 26;314(26):1676-86.

6. Morbidity and Mortality Weekly Report.

7. King MB, Tinetti ME. Falls in community-dwelling older persons. J Am Geriatr Soc. 1995; 43:1146-54.

8. Cutson TM. Falls in the elderly. Am Fam Physician. 1994 Jan;49(1):149-56.

9. Hindmarsh JJ, Estes EH. Falls in older persons: causes and interventions. Arch Intern Med. 1989; 149:2217-22.

10. Rubenstein LZ, Robbins AS, Schulman BL et al. Falls and instability in the elderly. J Am Geriatr Soc. 1988; 36:266-78.

11. Granek E, Baker SP, Abbey H et al. Medications and diagnoses in relation to falls in a long-term care facility. J Am Geriatr Soc. 1987; 35:503-11

12, Liu BA, Topper AK, Reeves RA et al. Falls among older people: relationship to medication use and orthostatic hypotension. J Am Geriatr Soc. 1995; 43:1141-5.

13. Tinetti ME, Speechley M, Ginter SR. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988; 319:1701-7.

14. Lindsay R, Silverman SL, Cooper C, Hanley DA, etal. Risk of new vertebral fracture in the year following a fracture. JAMA. 2001 Jan 17;285(3):320-3.

15. Melton LJ, Atkinson EJ, Cooper C, et al. Vertebral fractures predict subsequent fractures. Osteoporos Int. 1999;10:214-221.

16. Black DM, Arden NK, Palermo L, Pearson J, Cummings SR. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1999 May;14(5):821-8

17. Zuckerman JD. Hip fracture. N Engl J Med. 1996 Jun 6;334(23):1519-25.

18. Keene GS, Parker MJ, Pryor GA. Mortality and morbidity after hip fractures. BMJ. 1993 Nov 13;307(6914):1248-50.

19.Epstein RS. Hip fractures in the elderly. How to reduce morbidity and mortality. Postgrad Med. 1988 Jul;84(1):254-7, 260.

20. Nevitt MC, Thompson DE, Black DM, Rubin SR, etal. Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group. Arch Intern Med. 2000 Jan 10;160(1):77-85.

21. Ismail AA, Cooper C, Felsenberg D, Varlow J, etal. Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group. Osteoporos Int. 1999;9(3):206-13.

22. Morrison RS, Siu AL. A comparison of pain and its treatment in advanced dementia and cognitively intact patients with hip fracture. J Pain Symptom Manage. 2000 Apr;19(4):240-8.

23. World Health Organization. Cancer pain relief and palliative care. Report of a WHO expert committee (World Health Organization Technical Report Series, 804). Geneva, Switzerland. WHO, 1990.

24. The Management of Chronic Pain in Older Persons. American Geriatrics Society, 1998.

25. Gloth FM, 3rd. Pain management in older adults: prevention and treatment. J Am Geriatr Soc 2001 Feb;49(2):188-99.

26. Shimp LA. Safety issues in the pharmacological management of chronic pan in the elderly. Pharmacotherapy 1998 Nov-Dec;18(6):1313-22.

27. Recommendations for the Medical Management of Osteoarthrits of the Hip and Knee. American College of Rheumatology Guidelines, 2000.

28. Henrich WL, Agodoa LE, Barrett B, Bennett WM, etal. Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis. 1996 Jan;27(1):162-5.

29. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999 Jun 17;340(24):1888-99.

30. Whelton A, Hamilton CW. Nonsteroidal anti-inflammatory drugs: effects on kidney function. J Clin Pharmacol. 1991 Jul;31(7):588-98.

31. Beier MT. Treatment of osteoarthritis in the elderly. Consult Pharm 2000;15(Suppl A):4–9.

32.Hawkey CJ. COX-2 inhibitors. Lancet. 1999 Jan 23;353(9149):307-14.

33. Physician Prescribing Information for Vioxx. Merck & Co.,Inc., Whitehouse Station, NJ. July 2000.

34.Clinical Pharmacology 2000. Gold Standard Multimedia.

35.Gloth FM.The role of cox-2 inhibitors in the treatment of osteoarthritis. Consult Pharm 2000;15(Suppl A):10–13.

36.Lyritis GP, Tsakalakos N, Magiasis B, Karachalios T, etal. Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study. Calcif Tissue Int. 1991 Dec;49(6):369-72.

37.Lyritis GP, Ioannidis GV, Karachalios T, Roidis N, etal. Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study. Clin J Pain. 1999 Dec;15(4):284-9.

return to top of page